Company ProfileFounded by scientist and inventor Dr Lim Yoon Pin, a professor at NUS who specializes in cancer research, biomarker discovery and validation. Dr Lim currently holds 10 patents across USA, China, UK and Singapore with several pending award in the space of cancer detection and precision medicine.Startup has an established proprietary biomarker discovery and validation infrastructure for stratification of patients for response to anti-cancer drugs. We welcome collaborations.Startup is involved in R&D of In Vitro Diagnostics kits and plans to conduct clinical trials in ASEAN, ASIA, US and EU. To this end, we are looking for global partners in R&D of Immunohistochemistry-based detection kit and pharma, hospitals and/or histopathological labs to conduct relevant clinical studies.